| Carcinogenicity of perfluorooctanoic acid and perfluorooctanesulfonic acid S Zahm, JP Bonde, WA Chiu, J Hoppin, J Kanno, M Abdallah, ... The Lancet Oncology 25 (1), 16-17, 2024 | 111 | 2024 |
| The out-of-field dose in radiation therapy induces delayed tumorigenesis by senescence evasion E Goy, M Tomezak, C Facchin, N Martin, E Bouchaert, J Benoit, ... Elife 11, e67190, 2022 | 21 | 2022 |
| Concurrent imaging of vascularization and metabolism in a mouse model of paraganglioma under anti-angiogenic treatment C Facchin, M Perez-Liva, A Garofalakis, T Viel, A Certain, D Balvay, ... Theranostics 10 (8), 3518, 2020 | 17 | 2020 |
| Performance evaluation of the PET component of a hybrid PET/CT-ultrafast ultrasound imaging instrument M Perez-Liva, T Viel, T Yoganathan, A Garofalakis, J Sourdon, C Facchin, ... Physics in Medicine & Biology 63 (19), 19NT01, 2018 | 15 | 2018 |
| Advisory Group recommendations on priorities for the IARC Monographs AB de González, SA Masten, P Bhatti, RT Fortner, S Peters, T Santonen, ... The Lancet Oncology 25 (5), 546-548, 2024 | 13 | 2024 |
| Sunitinib-induced cardiac hypertrophy and the endothelin axis J Sourdon, C Facchin, A Certain, T Viel, B Robin, F Lager, C Marchiol, ... Theranostics 11 (8), 3830, 2021 | 13 | 2021 |
| Carcinogenicity of talc and acrylonitrile LT Stayner, T Carreón-Valencia, PA Demers, JM Fritz, MR Sim, P Stewart, ... The Lancet Oncology 25 (8), 962-963, 2024 | 5 | 2024 |
| FIBER-ML, an open-source supervised machine learning tool for quantification of fibrosis in tissue sections C Facchin, A Certain, T Yoganathan, C Delacroix, AA Garcia, F Gaillard, ... The American Journal of Pathology 192 (5), 783-793, 2022 | 4 | 2022 |
| Machine learning of multi-modal tumor imaging reveals trajectories of response to precision treatment N Mansouri, D Balvay, O Zenteno, C Facchin, T Yoganathan, T Viel, ... Cancers 15 (6), 1751, 2023 | 3 | 2023 |
| Molecular Analysis of the Superior Efficacy of a Dual Epidermal Growth Factor Receptor (EGFR)-DNA-Targeting Combi-Molecule in Comparison with Its Putative Prodrugs 6-Mono … C Facchin, AB Fraga-Timiraos, J Schmitt, N Babaa, N Pannu, A Aliaga, ... Cells 12 (6), 914, 2023 | 2 | 2023 |
| Carcinogenicity of hydrochlorothiazide, voriconazole, and tacrolimus VJ Cogliano, E Corsini, A Fournier, HH Nelson, CM Sergi, AMM Antunes, ... The Lancet Oncology 26 (1), 15-16, 2025 | | 2025 |
| 457 (PB445): Engineering smart molecules to stimulate the immune system A Timiraos, C Facchin, N Babaa, AL Larroque-Lombard, B Jean-Claude European Journal of Cancer 211, 114965, 2024 | | 2024 |
| P13-17 Assessment of the efficiency of the literature search of the ten key characteristics of carcinogens in the IARC Monographs evaluation process C Facchin, A De Conti, L Benbrahim-Tallaa, S Chittiboyina, S Ruiz, ... Toxicology Letters 399, S216, 2024 | | 2024 |
| Synthesis and biological activities of a novel series of combi-molecules designed to delay metabolic dealkylation prior to crossing the blood brain barrier in the context of … AB Fraga-Timiraos, C Facchin, AL Larroque-Lombard, BJ Jean-Claude MOLECULAR CANCER THERAPEUTICS 22 (12), 2023 | | 2023 |
| Abstract A034: Synthesis and biological activities of a novel series of “combi-molecules” designed to delay metabolic dealkylation prior to crossing the blood brain barrier in … AB Fraga-Timiraos, C Facchin, AL Larroque-Lombard, BJ Jean-Claude Molecular Cancer Therapeutics 22 (12_Supplement), A034-A034, 2023 | | 2023 |
| In vivo efficacy and metabolism of a new synthetized dual EGFR-DNA targeting combi-molecule in a human stem cells-derived model of glioblastoma implanted … C Facchin, ABF Timiraos, B Meehan, N Babaa, L Adnani, AL Larroque, ... Cancer Research 83 (7_Supplement), 1647-1647, 2023 | | 2023 |
| Synthesis and optimization of small molecules designed to stimulate the immune system by inducing DNA damage and blocking PD-1/PD-L1 ABF Timiraos, C Facchin, N Babaa, AL Larroque-Lombard, ... Cancer Research 83 (7_Supplement), 3104-3104, 2023 | | 2023 |
| Machine Learning of Multi-Modal Tumor Imaging Reveals Trajectories of Response to Precision Treatment. Cancers 2023, 15, 1751 N Mansouri, D Balvay, O Zenteno, C Facchin, T Yoganathan, T Viel, ... | | 2023 |
| Superior efficacy of a dual EGFR-DNA targeting combi-molecule “ZR2002” in comparison with its analogues 6-mono-alkylamino-and 6, 6-dialkylaminoquinazoline in a human … C Facchin, AL Larroque, A Alliaga, AF Timiraos, B Jean-Claude European Journal of Cancer 174, S16, 2022 | | 2022 |
| DNA Single-Strand breaks and cell senescence: the two steps towards second cancer post-radiotherapy E Goy, M Tomezak, N Martin, C Facchin, AD Pourtier, O Pluquet, P Brodin, ... 2nd PhD days of the OncoLille Institute, 2021 | | 2021 |
